Afegostat tartrate

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameAfegostat tartrate
Drug Alias NamePlicera-ERT combo therapyisofagomine-ERT combo therapyIsofagomine tartratePliceraNN-42-1007 +[7] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBeta-glucocerebrosidase inhibitors
TargetsBeta-glucocerebrosidase
Therapy Area/IndicationsGaucher's disease type IGaucher Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesSouth AfricaUnited Kingdom +[4] 
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAmicus Therapeutics IncShire Development Llc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAmicus Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsGaucher's disease type IGaucher Disease

Other Information

ATC CodeN/A
Related LinksWikipediaKEGG